1. Currently, almost 93% of patients suffering from regionally contained cancer survive five years following the diagnosis, according to the National Cancer Institute, which may be explained by more accurate methods of diagnosis and cutting-edge discoveries in the field.

Lymphoma is a type of cancer that affects the lymphatic system, particularly the white blood cells called lymphocytes. The most common types of lymphoma are Hodgkin’s lymphoma and non-Hodgkin’s lymphoma.

2. There are about 65,500 new cases of lymphoma diagnosed annually in the US alone.

Many people have been and still are fighting lymphoma. Learn more about WWF wrestler, bodyguard, “The A-Team” TV star and movie actor, Mr. T’s battle with T-cell lymphoma.

3. About 20,000 people die each year due to the disease.

Recently a study found that lymphoma patients who undergo a hematopoietic stem cell transplant (HSCT) from a tissue-matched donor have similar survival rates to those receiving HSCT from sibling donors. 

4. The average age of diagnosis is 66 years old and the probability of suffering from the disease rises proportionally with age.

Clinical trials are extremely important scientific studies that are needed and required to assess new medical treatments, including treatments for diseases such as lymphoma. Learn more about why we need clinical trials for lymphoma 

5. The probability of contracting lymphoma is higher among men than women.

Learn more about cancer-related fatigue and how to manage it.

6. The average age of death is 75.

Learn more about where to find information on lymphoma clinical trials and which current notable lymphoma clinical trials are available now, here.

7. The Surveillance Epidemiology and End Results (SEER) of the National Cancer Institute revealed the five-year relative survival tendency of patients who suffer from lymphoma.

Learn more about how to apply the growing understanding of the biology of lymphoma.

8. Early-stage (I) with localized disease has an 81.1% survival rate.

Learn more about how PET scans can guide chemotherapy choices for Hodgkin’s lymphoma.

9. Early-stage (I, II) with localized cancer has a 70.5% survival rate.

Learn more about where to find information on lymphoma clinical trials and which current notable lymphoma clinical trials are available now, here.

10. Later-stage (III, IV), metastasized cancer has a 58.5% survival rate.

Learn more about how to apply the growing understanding of the biology of lymphoma.

11. The increase in survival rate is considered a success of cancer research.

Clinical trials are extremely important scientific studies that are needed and required to assess new medical treatments, including treatments for diseases such as lymphoma. Learn more about why we need clinical trials for lymphoma 

12. In addition to timing, the survival rate of lymphoma patients is also conditioned by the type of lymphoma in question and treatment chosen.

Many people have been and still are fighting lymphoma. Learn more about WWF wrestler, bodyguard, “The A-Team” TV star and movie actor, Mr. T’s battle with T-cell lymphoma.

Lymphoma News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Print This Page